New Prospective Phosphodiesterase Inhibitors: Phosphorylated Oxazole Derivatives in Treatment of Hypertension.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 399, doi. 10.34172/apb.2023.044
- By:
- Publication type:
- Article
Works matching IS 22285881 AND DT 2023 AND VI 13 AND IP 2
Results: 22
1
2
The Impact of Single Nucleotide Polymorphisms on the Pharmacokinetics of Tacrolimus in Kidney Allograft Recipients of Northern-West, Iran.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 393, doi. 10.34172/apb.2023.038
- By:
- Publication type:
- Article
3
Comparative Evaluation of Lipofectamine and Dendrimer for Transfection of Short RNA Into Human T47D and MCF-10A Cell Lines.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 385, doi. 10.34172/apb.2023.022
- By:
- Publication type:
- Article
4
The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 378, doi. 10.34172/apb.2023.041
- By:
- Publication type:
- Article
5
Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 368, doi. 10.34172/apb.2023.040
- By:
- Publication type:
- Article
6
The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 361, doi. 10.34172/apb.2023.043
- By:
- Publication type:
- Article
7
Restoring the Angiogenic Capacity of the Human Diabetic Adiposederived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 350, doi. 10.34172/apb.2023.021
- By:
- Publication type:
- Article
8
Optimized Signal Peptide for Secretory Expression of Human Recombinant Somatropin in E. coli.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 339, doi. 10.34172/apb.2023.037
- By:
- Publication type:
- Article
9
Cefazolin-Loaded Double-Shelled Hollow Mesoporous Silica Nanoparticles/Polycaprolactone Nanofiber Composites: A Delivery Vehicle for Regenerative Purposes.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 328, doi. 10.34172/apb.2023.032
- By:
- Publication type:
- Article
10
In Vitro Efficacy of Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles against MCF-7 Breast Cancer Cells.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 317, doi. 10.34172/apb.2023.035
- By:
- Publication type:
- Article
11
Liposome-Fe<sub>3</sub>O<sub>4</sub>-Doxorubicin Mediated Treatment of Melanoma Tumors.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 309, doi. 10.34172/apb.2023.034
- By:
- Publication type:
- Article
12
Preparation and Characterization of Magnetic Solid Lipid Nanoparticles as a Targeted Drug Delivery System for Doxorubicin.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 301, doi. 10.34172/apb.2023.033
- By:
- Publication type:
- Article
13
Preparation and Characterization of Undecylenoyl Phenylalanine Loaded-Nanostructure Lipid Carriers (NLCs) as a New α-MSH Antagonist and Antityrosinase Agent.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 290, doi. 10.34172/apb.2023.036
- By:
- Publication type:
- Article
14
Electrosprayed Nanoparticles Containing Hydroalcoholic Extract of Echinacea purpurea (L.) Moench Stimulates Immune System by Increasing Inflammatory Factors in Male Wistar Rats.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 283, doi. 10.34172/apb.2023.031
- By:
- Publication type:
- Article
15
Chitosan and Its Structural Modifications for siRNA Delivery.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 275, doi. 10.34172/apb.2023.030
- By:
- Publication type:
- Article
16
Probiotics for the Management of Oral Mucositis: An Interpretive Review of Current Evidence.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 269, doi. 10.34172/apb.2023.029
- By:
- Publication type:
- Article
17
Current and Novel Emerging Medical Therapies for Peripheral Artery Disease: A Literature Review.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 259, doi. 10.34172/apb.2023.025
- By:
- Publication type:
- Article
18
Stem Cell's Secretome Delivery Systemsv.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 244, doi. 10.34172/apb.2023.027
- By:
- Publication type:
- Article
19
Coenzyme Q10 and Its Therapeutic Potencies Against COVID-19 and Other Similar Infections: A Molecular Review.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 233, doi. 10.34172/apb.2023.026
- By:
- Publication type:
- Article
20
Polymersomes Based Versatile Nanoplatforms for Controlled Drug Delivery and Imaging.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 218, doi. 10.34172/apb.2023.028
- By:
- Publication type:
- Article
21
Pregnant and Breastfeeding Mothers Who Have Received the ChAdOx1 AstraZeneca COVID-19 Vaccine May Have Infants with an Increased Risk of Zinc Insufficiency and SCID Disease.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 216, doi. 10.34172/apb.2023.024
- By:
- Publication type:
- Article
22
Translational Phytomedicines against Cancer: Promise and Hurdles.
- Published in:
- Advanced Pharmaceutical Bulletin, 2023, v. 13, n. 2, p. 210, doi. 10.34172/apb.2023.023
- By:
- Publication type:
- Article